Agents and Actions

, Volume 10, Issue 4, pp 378–388 | Cite as

Modulation of the immune system in the mouse 1. Drug administration prior to antien sensitization

  • Jean Cottney
  • John Bruin
  • Alan J. Lewis
Immunosuppression and Inflammation

Abstract

A model has been developed in the mouse in which metylated bovine serum albumin (MBSA) and sheep red blood cells have been used to produced delayed type hypersensitivity (DTH) and humoral immunity (HI), respectively.

The time coruse between antigen sensitization and challenge was chosen such that cyclophosphamide (CY), administered prior to sensitization, produced DTH enhancement and also produced suppression of HI when administered at high doses. A number of other drugs have been examined in this model but only CY-like drugs, viz. alkylating agents, produced similar DTH enhancement. DTH was suppressed in a few cases.

The HI response was enhanced or suppressed by a number of unrelated drugs. CY was the only alkylatng agent to suppress the antibody titre.

The mechanisms for these drug effects are uncertain. However, a number of drugs elicit effects on either DTH or HI which suggests there is selective removal of certain cell populations rather than non-specific cytotoxicity. Possible theories for the effects observed are discussed.

These studies also suggest that CY possesses unique properties in this particular model.

Keywords

Albumin Blood Cell Immune System Bovine Serum Bovine Serum Albumin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    J.L. Turk, D. Parker andL.W. Poulter,Functional Aspects of the Selective Depletion of Lymphoid Tissue by Cyclophosphamide, Immunology23, 493–501 (1972).PubMedGoogle Scholar
  2. [2]
    J.L. Turk andD. Parker,Further Studies on B-Lymphocyte Suppression in Delayed Hypersensitivity. Indicating a Possible Mechanism for Jones-Mote Hypersensitivity, Immunology24, 751–758 (1973).PubMedGoogle Scholar
  3. [3]
    P.H. Lagrange, G.B. Mackaness andT.E. Miller,Potentiaton of T-Cell-mediated Immunity by Selective Suppression of Antibody Formation with Cyclophosphamide, J. Exp. Med.139, 1529–1539 (1974).PubMedGoogle Scholar
  4. [4]
    J.A.M. Kerckaert,Influence of Cyclophosphamide on the Delayed Hypersensitivity in the Mouse after Intraperitoneal Immunization, Ann. Immunol.125c, 559–568 (1974).Google Scholar
  5. [5]
    J.A.M. Kerckhaert, G.J. van den Berg andJ.M.N. Willers,Influence of Cyclosphosphamide in the Delayed Hypersensitivity of the Mouse, Ann. Immunol.125c, 415–426 (1974).Google Scholar
  6. [6]
    P.W. Askenase, B.J. Hayden andR.K. Gershon,Angmentation of Delayed-type Hypersensitivity by Doses of Cyclophosphamide which do not Effect Antibody Responses, J. Exp. Med.141, 697–702 (1975).PubMedGoogle Scholar
  7. [7]
    A. Mitsuoka, B. Mitsuo andS. Morikawa,Enhancement of Delayed Hyper-sensitivity by Depletion of Suppressor T-Cells with Cyclophosphamide in Mice, Nature262, 77–78 (1976).PubMedGoogle Scholar
  8. [8]
    M. Zembala andG.L. Asherson,The Effect of Cyclophosphamide and Irradiation on Cells in the Mouse, Clin. exp. Immunol.23, 554–644 (1976).PubMedGoogle Scholar
  9. [9]
    H.K. Gill andF.Y. Liew,Regulation of Delayed-type Hypersensitivity. III. Effect of Cyclophosphamide on the Suppressor Cells for Delayed-type Hypersensitivity to Sheep Erythrocytes in Mice, Eur. J. Immunol.8, 172–176 (1978).Google Scholar
  10. [10]
    S.I. Katz, D. Parker andJ.L. Turk,B-Cell Suppression of Delayed Hypersensitivity, Nature251, 550–551 (1974).PubMedGoogle Scholar
  11. [11]
    R. Neta andS.B. Saluin,Specific Suppression of Delayed Hypersensitivity. The Possible Presence of a Suppressor B-Cell in the Regulation of Delayed Hypersensitivity, J. Immunol.113, 1716–1725 (1974).PubMedGoogle Scholar
  12. [12]
    H. Duclos, H. Galanaud, P.O. Devinsky, M.-C. Maillot andJ. Dormont,Enhancing Effect of Low Dose Cyclophosphamide Treatment on the in vitro Antibody Response, Eur. J. Immunol.7, 679–684 (1977).PubMedGoogle Scholar
  13. [13]
    A.J., Crowle, C.C. Hu andA. Patrucco,Preferential Development by Mice of Delayed Hypersensitivity to Purified Basic Proteins, J. Allergy42, 140–156 (1969).Google Scholar
  14. [14]
    J. Bruin, J. Cottney, D.K. Gemmell andA.J. Lewis,The Effect of Several Immunomodulating Agents on a Model of Humoral and Cell Mediated Immunity in the Mouse, Br. J. Pharmac. (in press).Google Scholar
  15. [15]
    I.L. Bonta andJ. Nordhoek,Anti-inflammatory Mechanism of Inflamed Tissue Factor, Agents and Actions3, 348–356 (1973).PubMedGoogle Scholar
  16. [16]
    A. Schwartz, P. W. Askenase andR.K. Gershon,Regulation of Delayed-type Hypersensitivity Reactions by Cyclophosphamide Sensitive T-cells, J. Immunol.121, 1573–1577 (1978).PubMedGoogle Scholar
  17. [17]
    B. Noble, D. Parker, R.J. Scheper andJ.L. Turk,The Relation Between B-Cell Stimulation and Delayed Hypersensitivity: the Effect of Cyclophosphamide Pretreatment on Antibody Production, Immunology32, 885–892 (1977).PubMedGoogle Scholar
  18. [18]
    D. Parker andJ.L. Turk,The Effect of Cyclophosphamide Pretreatment on B-Cell Stimulation: Dissociation of Action on Homocytotropic Antibody and other B-Cell Functions, Immunology34, 115–121 (1978).PubMedGoogle Scholar
  19. [19]
    N. Chiorazzi, D.A. Fox andD.H. Katz,Haptenspecific IgE Antibody Responses in Mice. VI. Selective Enhancement of IgE Antibody Production by Low Doses of X-tradiation and by Cyclophosphamide, J. Immunol.117, 1629–1637 (1976).PubMedGoogle Scholar
  20. [20]
    M. Taniguchi andT. Tada,Regulation of Homocytotropic Antibody Formation on the Rat. IV. Effects of Various Immunosuppressive Drugs, J. Immunol.107, 579–585 (1971).PubMedGoogle Scholar
  21. [22]
    A.R. Mackenzie, C.R. Pick, P.R. Sibley andB.P. White,Suppression of Rat Adjuvant Disease by Cyclophosphamide Pretreatment: Evidence for an Antibody Mediated Component in the Pathogenesis of the Disease, Clin. Exp. Immunol.32, 86–96. (1978).PubMedGoogle Scholar
  22. [23]
    M.C. Berenbaum,Immunosuppressive Agents and Allogenic Transplantation, J. clin. Path.20, 471–498 (1967).Google Scholar
  23. [24]
    R.J. Scheper, D. Parker, B. Noble andJ.L. Turk,The Relation of Immune Depression and B-Cell Stimulation During the Development of Delayed Hypersensitivity to Soluble Antigents, Immunology32, 265–272 (1977).Google Scholar
  24. [25]
    L. Levy,Effect of Predosing Animals with Immunosuppressive Drugs on Immune and Non-immune Induced Inflammatory Responses, Arch. int. Pharmacodyn.211, 8–17 (1974).PubMedGoogle Scholar
  25. [26]
    W.D. Dewys, A. Goldin andN. Mantel,Haemopoietic Recovery After Cyclophosphamide: Cor relation of Proliferative State with Sensitivity, Cancer Res.30, 1692–1697 (1970).PubMedGoogle Scholar
  26. [27]
    J.L. Turk andL.W. Poulter,Selective Depletion of Lymphoid Tissue by Cyclophosphamide, Clin. exp. Immunol.10, 285–296 (1972).PubMedGoogle Scholar
  27. [28]
    G.D. Stockman, L.R. Heim, M.A. South andJ.J. Trentin,Differential Effects of Cyclophosphamide on the B- and T-Cell Compartments of Adult Mice, J. Immunol.110, 277–282 (1973).PubMedGoogle Scholar
  28. [29]
    F. Dumont,Destruction and Regeneration of Lymphocyte Populations in the Mouse Spleen After Cyclophosphamide Treatment, Int. Arch. Allergy47, 110–123 (1974).PubMedGoogle Scholar
  29. [30]
    M.C. Berenbaum,The Action of Antimitotic Substances on the Immune Response, Pathol. Biol.9, 963–966 (1961).Google Scholar
  30. [31]
    G.H. Heppner andP. Calabresi,Selective Suppression of Humoral Immunity by Antineoplastic Drugs, Ann. Rev. Pharmac. Toxicol.16, 367–379 (1976).Google Scholar

Copyright information

© Birkhäuser Verlag 1980

Authors and Affiliations

  • Jean Cottney
    • 1
  • John Bruin
    • 1
  • Alan J. Lewis
    • 1
  1. 1.Scientific Development GroupOrganon Laboratories LimitedNewhouseScotland

Personalised recommendations